Adc Therapeutics Sa (ADCT)

SG&A Expense Growth

-1.46%

Quarterly · Period ending:

ADCT logo

ADCT SG&A Expense Growth

Latest reported-1.46%
ADCT Quarterly SG&A Growth (QoQ) (0.00% → -1.46%)
High-resolution chart · PNG

ADCT sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Adc Therapeutics Sa SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-1.4643%
5.4193%
12.7695%
0.2372%
3,272.0736%
-102.8648%
0.9625%
-1.2608%
-10.5973%
-7.1406%
9.2287%
-12.7258%
-14.2477%
-1.469%
-14.1235%
21.4697%
-19.6945%
2.3324%
8.6138%
-2.764%
9.8276%
6.9408%
45.2622%
6.7056%
123.255%
72.9675%
113.7272%
-43.7026%
24.0595%
37.362%
0%
20.9121%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.